Palo Alto, CA – February 6, 2025 – LVIS Corporation has announced the launch of NeuroMatch Pro, an advanced AI-driven platform that builds on the foundation of NeuroMatch to enhance EEG diagnostics. The platform introduces Seizure Detection and Spike Detection, providing powerful tools for the real-time identification and management of seizures and epilepsy-related spike activity.
The Seizure Detection feature uses deep-learning algorithms to automatically identify seizure events, validated through thousands of hours of 19-channel EEG data. The system notifies physicians of detected seizures within an hour, enabling quick intervention. Similarly, Spike Detection identifies spikes and sharp wave events, crucial markers for diagnosing and managing epilepsy. Both features are FDA-cleared for clinical use and offer physicians the ability to review, validate, or adjust detected events based on their clinical expertise.
NeuroMatch Pro addresses the limitations of traditional seizure and spike detection systems, which often lack flexibility. Unlike other platforms, NeuroMatch Pro allows for seamless integration of physician judgment into the analysis, making it a more reliable and accurate tool for clinical decision-making.
Launched in the United States in January of 2025, NeuroMatch Pro has already been successfully deployed in more than 10 hospitals in South Korea. The platform’s ability to automate key aspects of EEG interpretation streamlines clinical workflows, helping healthcare providers expand services while maintaining diagnostic accuracy.
About LVIS Corporation
LVIS Corporation, headquartered in Palo Alto, California, is a leader in neurotechnology, committed to advancing patient care through innovative AI-driven solutions in neurological diagnostics and treatment. For more information or to schedule a demonstration, visit www.lviscorp.com.